SNHG15 could act as an oncogene in pancreatic cancer, further research found that SNHG15 knockdown inhibited proliferative capacities and suppressed apoptotic rate of pancreatic cancer cells in vitro, and impaired in vivo tumorigenicity (Ma et al., 2017). Here, SNHG15 is linked to familial pancreatic carcinoma.